CMS Urged To Test Monthly $35 Caps For More Than Just Insulin

By Gabrielle Wanneh / November 16, 2022 at 10:16 AM
Seniors’ advocates are using the new drug pricing law’s $35 monthly cap on insulin costs as leverage for testing $35 out-of-pocket caps on other drugs. However, Avalere projects that capping drug costs would increase Medicare spending, and by law successful demonstrations cannot increase Medicare costs. President Joe Biden in October wrote an executive order that directs CMS’ innovation center to assess new ways of lowering prescription drug costs; recommendations are due in January. The Alliance for Aging Research has met...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.